https://www.avient.com/sites/default/files/2024-08/AVNT Second Quarter Earnings Press Release.pdf
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the
establishment, reversal or changes to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
June 30, 2024
December 31,
2023
ASSETS
Current assets:
Cash and cash equivalents $ 489.4 $ 545.8
Accounts receivable, net 486.6 399.9
Inventories, net 365.9 347.0
Other current assets 117.2 114.9
Total current assets 1,459.1 1,407.6
Property, net 1,019.9 1,028.9
Goodwill 1,685.1 1,719.3
Intangible assets, net 1,515.7 1,590.8
Other non-current assets 228.0 221.9
Total assets $ 5,907.8 $ 5,968.5
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 657.7 $ 9.5
Accounts payable 435.2 432.3
Accrued expenses and other current liabilities 405.3 331.8
Total current liabilities 1,498.2 773.6
Non-current liabilities:
Long-term debt 1,420.8 2,070.5
Pension and other post-retirement benefits 63.3 67.2
Deferred income taxes 276.3 281.6
Other non-current liabilities 315.0 437.6
Total non-current liabilities 2,075.4 2,856.9
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,317.5 2,319.2
Noncontrolling interest 16.7 18.8
Total equity 2,334.2 2,338.0
Total liabilities and equity $ 5,907.8 $ 5,968.5
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Six Months Ended
June 30,
2024 2023
Operating Activities
Net income $ 83.5 $ 42.7
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization 88.4 96.2
Accelerated depreciation 0.8 1.9
Share-based compensation expense 9.0 6.5
Changes in assets and liabilities:
Increase in accounts receivable (97.0) (66.6)
(Increase) decrease in inventories (27.3) 14.0
Increase (decrease) in accounts payable 11.9 (26.2)
Taxes paid on gain on sale of business — (103.0)
Accrued expenses and other assets and liabilities, net (6.2) 9.8
Net cash provided (used) by operating activities 63.1 (24.7)
Investing activities
Capital expenditures (55.8) (45.9)
Net proceeds from divestiture — 7.3
Proceeds from plant closures 3.4 —
Other investing activities (2.1) —
Net cash used by investing activities (54.5) (38.6)
Financing activities
Cash dividends paid (47.0) (45.0)
Repayment of long-term debt (4.5) (1.0)
Other financing activities (3.3) (2.3)
Net cash used by financing activities (54.8) (48.3)
Effect of exchange rate changes on cash (10.2) (0.8)
Decrease in cash and cash equivalents (56.4) (112.4)
Cash and cash equivalents at beginning of year 545.8 641.1
Cash and cash equivalents at end of period $ 489.4 $ 528.7
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to
segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not
included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
DEDICATED HEALTHCARE EXPERTS
Our global and regional team of technical specialists
provide support for multiple projects including
global transfers, troubleshooting, and developing
the right solution for each need.
APPLICATION PORTFOLIO DESCRIPTION
General use Opaque and transparent colors in PP, PE, COC, ABS,
POM, PC, TPU, PEEK, and more
Needle hubs and cannulae Opaque and translucent colors evaluated to ISO 6009
Ophthalmic caps and closures 13 standard colors in PE matched to American Academy of
Ophthalmology; biologically evaluated to USP standard
White pharmaceutical packaging White colorants for PE, HDPE, PP covering solid dose
to nasal packaging needs
Amber pharmaceutical packaging Pre-tested amber colorants
LSR silicones For LSR silicones and transparent color PET/PP (e.g. amber)
FUNCTIONALITY ADDITIVE PERFORMANCE
UV protection in transparent packaging Blocks UV in 290–450nm for PP, PE, PETG, COP
Processing aid/friction reduction Optimizes processing for PE, PP, ABS, POM—non-migrating
Nucleation for reduced material
consumption/cycle time
Improves thermal and mechanical properties of PE and PP
and allows wall thinning to support sustainability
Clarifying Improves clarity of transparent PP applications with reduced
migration and improved thermal stability—sorbitol-free
Laser marking/welding Activates the polymer to absorb Nd-YAG laser
for fast reliable marking/assembly
Gamma/e-beam sterilization Preserves the properties of PP and COP,
reduces yellowing and compensates for discoloration
Anti-static Reduces static buildup in applications such as films in
API handling and inhaler spacers/nebulizers
Antioxidant Provides thermal protection during converting/
downstream sterilization
Anti-counterfeit/brand protection Covert and non-covert systems
SUPPORTING SUSTAINABILITY
TARGETS
As the need to integrate sustainability in the design
of healthcare products is growing, manufacturers
of medical devices, diagnostic products and
pharmaceutical packaging are looking for
materials with a more environmentally friendly
profile.
https://www.avient.com/sites/default/files/2022-05/ColorMatrix Amosorb Solo Technical Bulletin.pdf
Active and passive oxygen barriers are additives
that are broadly used in the PET bottle industry,
across the value chain; they guarantee the optimal
shelf life of packaged goods such as beer, juices,
RTD beverages, or condiments, to name a few.
Five consecutive melt histories (left to
right) are pictured.
https://www.avient.com/sites/default/files/2024-03/2024 Proxy Statement_March.pdf
Stock-Settled Stock Appreciation Rights.
4) Modification of Stock Appreciation Rights in Connection with Retirement.
Holders of common shares have no cumulative
voting rights.
https://www.avient.com/sites/default/files/2021-02/avients-publication-of-uk-tax-strategy.pdf
It will also make sure that such planning will support Avient
Group’s commercial strategies and economic activities in the UK.
Approach with Her Majesty’s Revenue and Customs (“HMRC”)
The Avient Group is committed to:
• promoting a professional, collaborative, open, and transparent relationship with HMRC
• discussing business activities and transactions with significant tax implications with HMRC in a timely
fashion
• engaging in timely dialogue with HMRC to respond to queries and information requests to ensure that
HMRC is aware of how issues are progressing
• working proactively with HMRC to resolve all tax disputes, and
• making appropriate disclosures in tax returns, reports, and correspondence submitted to HMRC.
https://www.avient.com/sites/default/files/2022-09/Cesa Laser Marking Additives for Transportation Industry Bulletin.pdf
During processing, a laser
beam activates laser sensitive
additives within a masterbatch.
The activation changes the
molecular structure of these
additives, causing a color change
that provides the vivid contrast
of laser marking.
https://www.avient.com/sites/default/files/2024-09/Avient_RY 2023 CDP Verification Opinion Declaration.pdf
Verification activities applied in a limited level of assurance
verification are less extensive in nature, timing and extent than in a reasonable level of assurance verification.
Boundaries of the reporting company GHG emissions covered by the verification:
• Operational Control
• Global
Exclusions:
• Fugitive refrigerants from units
Apex has implemented a Code of Ethics across the business to maintain high ethical standards among staff in their
day-to-day business activities.
https://www.avient.com/sites/default/files/2023-03/Avient Annual Report 2022.pdf
Employee Recruitment
Avient’s success is driven by having the best talent in the right roles.
Cash Flows
The following table summarizes our cash flows from operating, investing and financing activities:
Cash provided by (used by):
Operating Activities $ 398.4 $ 233.8 $ 221.6
Investing Activities (504.0) (150.2) (1,431.6)
Financing Activities 166.4 (114.6) 982.0
Effect of exchange rate on cash (20.9) (17.3) 12.8
Net increase (decrease) in cash and cash equivalents $ 39.9 $ (48.3) $ (215.2)( ) ( )
Operating activities
In 2022, net cash provided by operating activities increased to $398.4 million as compared to $233.8 million in 2021,
as a result of a reduction in working capital, offset by higher incentive payments in 2022 associated with 2021
performance.
Restricted Stock Units
RSUs represent contingent rights to receive one common share at a future date provided certain vesting criteria are
met.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Poland.pdf
Buyer
shall have no right of set-off.
Buyer agrees to indemnify and hold harmless Seller
from and against any liability (including fines or legal fees)
incurred by Seller with respect to any export or re-export
activities by Buyer in violation of its obligations under the
applicable laws.
Within 10 (ten) days after receipt of
such notice, Seller may exercise its right to terminate the
sale contract by giving Buyer written notice.
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Press Release-1.pdf
2) Tax adjustments include the net tax benefit/(expense) from non-recurring income tax items, adjustments to uncertain tax position reserves and
deferred income tax valuation allowances.
11
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets (Unaudited)
(In millions)
Year Ended
December 31,
2022 2021
ASSETS
Current assets:
Cash and cash equivalents $ 641.1 $ 601.2
Accounts receivable, net 440.6 439.9
Inventories, net 372.7 305.8
Current assets held for sale — 360.2
Other current assets 115.3 119.9
Total current assets 1,569.7 1,827.0
Property, net 1,049.2 672.3
Goodwill 1,671.9 1,284.8
Intangible assets, net 1,597.6 925.2
Operating lease assets, net 60.4 58.2
Non-current assets held for sale — 22.0
Other non-current assets 136.2 207.7
Total assets $ 6,085.0 $ 4,997.2
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 2.2 $ 8.6
Accounts payable 454.4 429.5
Current operating lease obligations 17.0 21.1
Current liabilities held for sale — 141.3
Accrued expenses and other current liabilities 395.8 340.2
Total current liabilities 869.4 940.7
Non-current liabilities:
Long-term debt 2,176.7 1,850.3
Pension and other post-retirement benefits 67.2 99.9
Deferred income taxes 342.5 100.6
Non-current operating lease obligations 40.9 37.3
Non-current liabilities held for sale — 13.1
Other non-current liabilities 235.5 164.8
Total non-current liabilities 2,862.8 2,266.0
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,334.5 1,774.7
Noncontrolling interest 18.3 15.8
Total equity 2,352.8 1,790.5
Total liabilities and equity $ 6,085.0 $ 4,997.2
12
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Year Ended
December 31,
2022 2021
Operating activities
Net income $ 703.4 $ 230.6
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sale of business, net of tax expense (550.1) —
Depreciation and amortization 157.6 144.2
Accelerated depreciation 5.5 1.7
Amortization of inventory step-up 34.4 1.5
Deferred income tax expense (benefit) 0.5 (27.3)
Share-based compensation expense 13.2 11.2
Changes in assets and liabilities, net of the effect of acquisitions:
Decrease (increase) in accounts receivable 32.6 (143.1)
Decrease (increase) in inventories 14.0 (141.0)
Increase in accounts payable 10.7 95.3
Increase (decrease) in pension and other post-retirement benefits 7.1 (10.9)
Taxes paid on gain on divestiture (2.8) —
(Decrease) increase in accrued expenses and other assets and liabilities, net (27.7) 71.6
Net cash provided by operating activities 398.4 233.8
Investing activities
Capital expenditures (105.5) (100.6)
Business acquisitions, net of cash acquired (1,426.1) (47.6)
Settlement of foreign exchange derivatives 93.3 —
Proceeds from divestiture 928.2 —
Other investing activities 6.1 (2.0)
Net cash used by investing activities (504.0) (150.2)
Financing activities
Debt offering proceeds 1,300.0 —
Purchase of common shares for treasury (36.4) (4.2)
Cash dividends paid (86.8) (77.7)
Repayment of long-term debt (956.8) (18.5)
Payments on withholding tax on share awards (4.3) (10.7)
Debt financing costs (49.3) —
Other financing activities — (3.5)
Net cash provided (used) by financing activities 166.4 (114.6)
Effect of exchange rate changes on cash (20.9) (17.3)
Increase (decrease) in cash and cash equivalents 39.9 (48.3)
Cash and cash equivalents at beginning of year 601.2 649.5
Cash and cash equivalents at end of year $ 641.1 $ 601.2
13
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and
administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation
costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by
the chief operating decision maker.
Reconciliation of Pro Forma Net Debt
December 31,
2022
Short-term and current portion of long term debt $ 2.2
Total long-term debt, net 2,176.7
Unamortized discount and debt issuance cost 37.4
Total debt $ 2,216.3
Cash (641.1)
Net taxes due from sale of business 105.0
Adjusted cash $ (536.1)
Net debt $ 1,680.2
16
Free Cash Flow Calculation
December 31,
2022
Cash provided by operating activities 398.4
Capital expenditures (105.5)
Free cash flow $ 292.9
Reconciliation to EBITDA and Adjusted EBITDA
Year Ended
December 31, 2022
Net (loss) income from continuing operations – GAAP $ 83.1
Income tax (benefit) expense (19.3)
Interest expense 119.8
Depreciation and amortization from continuing operations 162.5
EBITDA $ 346.1
Special items, before income tax 194.0
Interest expense included in special items (26.0)
Depreciation and amortization included in special items (5.5)
APM pro forma adjustments - 8 months 2022* 83.1
Adjusted EBITDA $ 591.7
* Pro forma adjustment for January - August 2022 APM results (period before Avient ownership).